Karl Morten
Research Experience
PhD Bath University (1990)
Post Doctoral Positions (1990-2009)
Bristol University, Oxford University & The Buck Institute
for Research on Aging
Consultancy & Committees
London Technology Business Fellow (2006-2010)
Oxford Metabolism Committee (2014-)
MitOX (2009-)
Current Research Funding
ME Association UK, UK Spine Bridge and MLSTF Oxford
Group Members
Tiffany Lodge (Post Doctoral Researcher)
Inga Williams (PhD Student)
Jamie Strong (Data Assistant)
Sarah Hutchinson ( Post Doctoral Researcher)
Megan Stoker (MRes Student)
James Hulit ( Post Doctoral Fellow)
Edie Guo (PhD Student)
Morten Group ME/CFS Research Website
https://www.mortengroup.org.uk/
New Crowd funding
A call for funding for five new projects allows us to generate new data following on from our current research. This will take us closer to being competitive in open funding calls with the larger funding bodies.
We are currently working hard to publish our research generated over the last 3-4 years funded by grants from the ME Association. The papers and crowd funding will allow us to expand our research and bring in the experienced people we need to turn Oxford into a leading research centre for ME/CFS, Long Covid, Chronic Lyme Disease and PANS PANDAS
Karl Morten
Director of Graduate Studies and Principal Investigator.
RESEARCH GROUPS
I run an active research group with a focus on understanding the role of mitochondria in health and disease.
Current projects include
- targeting energy metabolism as a therapeutic strategy in cancer and
- identifying fatigue associated blood factors in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- development of Raman Microscopy as a tool to study energy metabolism and drug accumulation
Establishing collaborative research projects is one of my major passions and I am always interested in discussing exciting new projects.
Individuals interested in research in any of the areas mentioned are welcome to email me.
Enquiries from prospective PhD students are also welcome
Collaborations within NDWRH
- Professor Joanna Poulton: Investigating the pathogenesis and treatment strategies in patients with mitochondrial disease. Joanna and I have worked together on a wide range of projects for over 20 years
- Dr Helen Townley: Nanotherapeutic delivery of anti-cancer therapeutics. Project supported by Williams fund. Helen and I work closely developing novel nanoparticle drug combinations which can target cancer cell metabolism. Helen is part of NDWRH and runs a laboratory at the Begbroke Science Park.
- Dr Suzannah Williams: Developing metabolic tools to study follicular development.
Collaborations within Oxford
- Professor James McCullagh (Department of Chemistry). Using plasma mass spectrometry analysis to increase our understanding of ME/CFS.
- Professor Wei Huang (Department of Engineering). Exploring the use of Raman Microscopy as a diagnostic tool in ME/CFS and as a tool to study the biology of aging in vitro in collaboration with Horiba.
- Professor Helen Dawes and Dr Ryan Pink (Oxford Brookes University). Investigating the impact of plasma factors generated during exercise on cellular energetics from healthy controls and Parkinson's disease patients.
National and International Collaborators
- Professor Jeung Sang Go (Pussan National University, South Korea). Various microfluidic projects including i) Continual synthesis of protein-loaded nanoparticles, ii) microvesicle separation, and iii) 3D perfusion models for continual cell culture.
- SoftCell Biologicals and the Dove Clinic: Understanding the changes in plasma L-form bacterial load in ME/CFS patients following faecal microbiota transplantation (FMT) and the link to clinical improvement.
- Professor Elisa Oltra (Catholic University of Valencia San Vincente Martir): The role of exosomes and plasma factors in ME/CFS.
- Dr Pawel Zalewski (Nicolaus Copernicus University, Torun, Poland): Pawel is an essential clinical collaborator for our ME/CFS research programme providing us with clinically diagnosed patient plasma samples for our various research studies. The impact of a structured exercise programme and cryotherapy on clinical and biological markers of ME/CFS is also being explored.
Recent publications
-
Journal article
Su H. et al, (2025), Eur Heart J
-
Journal article
Davis L. et al, (2025), Front Neurosci, 19
-
Journal article
Gan E. et al, (2025), Methods Mol Biol, 2920, 29 - 37
-
Journal article
Xu J. and Morten KJ., (2024), Biochem Soc Trans
-
Journal article
Jayathilake PG. et al, (2024), PLoS Comput Biol, 20
Mitox event
The MitOX meeting at John Radcliffe Hospital is an annual meeting which brings together mitochondrial enthusiasts from Oxford and the South East. With around 150 delegates attending, the event is a fusion of face-to-face and online delegates and talks.
New cutting Edge research IN diagnostics and the identification of causal factors in ME/CFs, Long Covid and PANS PANDAS
We are looking to maintain momentum with a series of small research projects that build on our promising research.
- Intervention and Longitudinal studies which aim to move beyond simple associations and identify causal elements in ME/CFS and Long Covid
- Diagnostic projects looking to identify a diagnostic signature in ME/CFS, Long Covid and PANS PANDAS
Donations
Your donation will help fund vital research into the causes of ME/CFS, Long Covid, and PANS/PANDAS — bringing us closer to earlier diagnosis, better treatments, and improved care.
With 20–30 million people affected worldwide, and countless more impacted through family and friends, your support can help us reach our target and make a real difference.
Interview with Dr Binita Kane, Sajid Javid and Nick Benton a patient and his family. Covering ME and the new government delivery plan.
A talk covering energetic abnormalities in ME/CFS and links to Long Covid at a recent Physiology Society meeting.
A new study on Cryotherapy planned in ME/CFS, Long Covid and Post Treatment Lyme disease. Watch the video below by Nancy Klimas, Director of the Institute for Neuro-Immune Medicine